Cargando…

Comparison of oral and intravenous Alfacalcidol in chronic hemodialysis patients

BACKGROUND: Activated vitamin D is the mainstay of treatment for secondary hyperparathyroidism (SHPT) in chronic hemodialysis patients. However, the optimal route of administration is still debated. The aim of our study was to compare efficacy of oral vs intravenous (IV) administration of alfacalcid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lessard, Myriam, Ouimet, Denis, Leblanc, Martine, Nadeau-Fredette, Annie-Claire, Bell, Robert, Lafrance, Jean-Philippe, Pichette, Vincent, Vallée, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915223/ https://www.ncbi.nlm.nih.gov/pubmed/24495277 http://dx.doi.org/10.1186/1471-2369-15-27

Ejemplares similares

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Impact of Arteriovenous fistula creation on estimated glomerular filtration rate decline in Predialysis patients
por: Bénard, Valérie, et al.
Publicado: (2019)

Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk
por: Leclerc, Simon, et al.
Publicado: (2020)

Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec’s Reference Center
por: Leclerc, Simon, et al.
Publicado: (2021)

Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients
por: Pineault, Jérôme, et al.
Publicado: (2017)

A case of an aortic dissection in a young adult: a refresher of the literature of this “great masquerader”
por: Pineault, Jérôme, et al.
Publicado: (2011)

Retrospective Study Looking at Cinacalcet in the Management of Hyperparathyroidism after Kidney Transplantation
por: Mawad, Habib, et al.
Publicado: (2017)

An Unusual Initial Presentation of Lupus Nephritis as a Renal Mass
por: Goupil, Remi, et al.
Publicado: (2015)

A virtual ward for home hemodialysis patients – a pilot trial
por: Raphael, Michael J., et al.
Publicado: (2015)

Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial
por: Sawalmeh, Osama, et al.
Publicado: (2018)

Etelcalcetide Inhibits the Progression of Left Atrial Volume Index Compared to Alfacalcidol in Hemodialysis Patients
por: Dörr, Katharina, et al.
Publicado: (2023)

Home Hemodialysis and Peritoneal Dialysis Patient and Technique Survival in Canada
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2020)

Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends
por: Lafrance, Jean-Philippe, et al.
Publicado: (2013)

Early bioprosthetic valve calcification with alfacalcidol supplementation
por: Takano, Tamaki, et al.
Publicado: (2013)

Optimization of Dialysis Modality Transitions for Improved Patient Care
por: Imbeault, Benoit, et al.
Publicado: (2019)

Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents
por: Mawad, Habib, et al.
Publicado: (2016)

Alfacalcidol enhances collagen quality in ovariectomized rat bones
por: Nagaoka, Hideaki, et al.
Publicado: (2014)

Accessing hemodialysis clinics during the COVID-19 pandemic
por: Beaudet, Matthew, et al.
Publicado: (2022)

Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis
por: Lazrak, Hind Harrak, et al.
Publicado: (2017)

Infection control measures to prevent outbreaks of COVID-19 in Quebec hemodialysis units: a cross-sectional survey
por: Beaubien-Souligny, William, et al.
Publicado: (2021)

Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol
por: Nakamura, Toshitaka, et al.
Publicado: (2013)

Peroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
por: Li, Yuanying, et al.
Publicado: (2022)

Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study
por: Matuszkiewicz-Rowińska, Joanna, et al.
Publicado: (2022)

Assisted Peritoneal Dialysis Implementation: A Pilot Program From a Large Dialysis Unit in Quebec
por: Melanson, Julien, et al.
Publicado: (2022)

Quantification of Alfacalcidol Tablets Dissolution Content by Chemical Derivatization and LC-MS
por: Liu, Yang, et al.
Publicado: (2020)

Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
por: Giroux, Marjolaine, et al.
Publicado: (2021)

Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2022)

Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis
por: Goupil, Rémi, et al.
Publicado: (2021)

Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma.
por: Raina, V., et al.
Publicado: (1991)

Effects of alfacalcidol on cardiovascular outcomes according to alkaline phosphatase levels in the J-DAVID trial
por: Oka, Tatsufumi, et al.
Publicado: (2022)

Association of Glomerular Hyperfiltration and Cardiovascular Risk in Middle-Aged Healthy Individuals
por: Dupuis, Marie-Eve, et al.
Publicado: (2020)

Kidney Biopsy Findings Among Allogenic Hematopoietic Stem Cell Transplant Recipients With Kidney Injury: A Case Series
por: Roy, Guillaume, et al.
Publicado: (2023)

Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol
por: Hansen, Ditte, et al.
Publicado: (2009)

Dialysate calcium, alfacalcidol, and clinical outcomes: A post-hoc analysis of the J-DAVID trial
por: Iseki, Kunitoshi, et al.
Publicado: (2022)

Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis—a post-hoc analysis of a randomized, controlled trial
por: Dörr, Katharina, et al.
Publicado: (2023)

Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors
por: Asaoka, Daisuke, et al.
Publicado: (2016)

Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I
por: Iwamoto, Jun, et al.
Publicado: (2013)

A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol
por: Kubodera, Noboru
Publicado: (2009)

Eldecalcitol is more effective in promoting osteogenesis than alfacalcidol in Cyp27b1-knockout mice
por: Hirota, Yoshihisa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_de6h2ei9872364mhc0kv14th4c